showed that intraocular injection of lipoplexe (a nanosystem equipped with siRNA that inhibits HuR expression) in STZ-induced diabetic rats led to a significant decrease in retinal HuR and VEGF levels, achieving an improvement in diabetes-induced retinal symptoms [88]. This evidence concerns the gene VEGFA and diabetes mellitus.